WATERS CORP /DE/·4

Feb 27, 7:25 PM ET

Vergnano Mark 4

4 · WATERS CORP /DE/ · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Waters (WAT) Director Mark Vergnano Receives Equity Award

What Happened

  • Mark Vergnano, a director of Waters Corp (WAT), was granted equity on Feb 25, 2026: 23 shares of common stock (awarded at $0.00) and a derivative award of 57 shares (stock option) shown at $0.00. These were reported on a Form 4 filed Feb 27, 2026. This is an award/grant (compensation), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-25; filing date: 2026-02-27 (filed within the normal Form 4 timeframe).
  • Prices reported: $0.00 per share for both items (typical for grants/options at time of award).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes:
    • F1: The 23 shares are restricted stock that lapse (fully vest) on Feb 9, 2027.
    • F2: The 57-share derivative is a stock option; all underlying shares vest and become exercisable on Feb 9, 2027.
  • No indication this was a sale, gift to a third party, or a 10b5-1 plan transaction.

Context

  • This transaction is a standard equity compensation grant to a director. The awards do not represent an immediate market purchase or sale — the restricted shares and option vest on Feb 9, 2027, at which point Vergnano may exercise or sell (subject to company policy and trading windows). Such grants are common for executive/director compensation and are not by themselves a clear signal of insider market sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-25+234,540 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-02-25+5757 total
    Exercise: $319.44From: 2027-02-09Exp: 2036-02-25Common Stock (57 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.
  • [F2]All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.
Signature
/s/ Michael Lynn, attorney-in-fact for Mark Vergnano|2026-02-27

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT